We hypothesized that both Ki-67 scoring methods would indicate very good inter-observer agreement, as well as good agreement and correlation with SFP, and that Ki-67 could be an independent prognostic factor to predict survival and the benefit of systemic therapy in breast cancer patients. The gene discussed is MKI67; the disease is breast cancer.